Gene therapy for lung disease

被引:13
作者
Ennist, DL [1 ]
机构
[1] Genet Therapy Inc, Resp Gene Therapy Program, Gaithersburg, MD 20878 USA
关键词
D O I
10.1016/S0165-6147(99)01350-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene therapy is a new field of medical research that has great potential to influence the course of treatment of human disease, The lung has been a particularly attractive target organ for gene therapy due to its accessibility and the identification of genetic deficits for a number of lung diseases. Several clinical trials have shown evidence of low levels of gene transfer and expression, but without any benefit to the patients involved. Thus, current studies are focusing on further research and technological improvements to the vectors. Gene therapy is now beginning to benefit from a shift in emphasis from clinical trials to the development of better tools and procedures to deliver gene therapy to the bedside.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 131 条
[1]   Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands [J].
Adesanya, MR ;
Redman, RS ;
Baum, BJ ;
OConnell, BC .
HUMAN GENE THERAPY, 1996, 7 (09) :1085-1093
[2]   Novel gene switches for the regulation of gene expression [J].
Allgood, VE ;
Eastman, EM .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 :231-239
[3]  
ALTON EWF, 1909, GENE THER, V5, P291
[4]   NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE [J].
ALTON, EWFW ;
MIDDLETON, PG ;
CAPLEN, NJ ;
SMITH, SN ;
STEEL, DM ;
MUNKONGE, FM ;
JEFFERY, PK ;
GEDDES, DM ;
HART, SL ;
WILLIAMSON, R ;
FASOLD, KI ;
MILLER, AD ;
DICKINSON, P ;
STEVENSON, BJ ;
MCLACHLAN, G ;
DORIN, JR ;
PORTEOUS, DJ .
NATURE GENETICS, 1993, 5 (02) :135-142
[5]   Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted [J].
Amalfitano, A ;
Hauser, MA ;
Hu, HM ;
Serra, D ;
Begy, CR ;
Chamberlain, JS .
JOURNAL OF VIROLOGY, 1998, 72 (02) :926-933
[6]  
Anderson WF, 1998, NATURE, V392, P25
[7]  
[Anonymous], 1990, VIROLOGY
[8]   CHARACTERIZATION OF AN ADENOVIRUS GENE-TRANSFER VECTOR CONTAINING AN E4 DELETION [J].
ARMENTANO, D ;
SOOKDEO, CC ;
HEHIR, KM ;
GREGORY, RJ ;
STGEORGE, JA ;
PRINCE, GA ;
WADSWORTH, SC ;
SMITH, AE .
HUMAN GENE THERAPY, 1995, 6 (10) :1343-1353
[9]   Poly(lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo [J].
Beer, SJ ;
Matthews, CB ;
Stein, CS ;
Ross, BD ;
Hilfinger, JM ;
Davidson, BL .
GENE THERAPY, 1998, 5 (06) :740-746
[10]   Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].
Bellon, G ;
MichelCalemard, L ;
Thouvenot, D ;
Jagneaux, V ;
Poitevin, F ;
Malcus, C ;
Accart, N ;
Layani, MP ;
Aymard, M ;
Bernon, H ;
Bienvenu, J ;
Courtney, M ;
Doring, G ;
Gilly, B ;
Gilly, R ;
Lamy, D ;
Levrey, H ;
Morel, Y ;
Paulin, C ;
Perraud, F ;
Rodillon, L ;
Sene, C ;
So, S ;
TouraineMoulin, F ;
Schatz, C ;
Pavirani, A .
HUMAN GENE THERAPY, 1997, 8 (01) :15-25